Fritextsökning
Innehållstyper
-
Neanderthal gene variants may cause Viking disease
A new study suggests that the so-called Viking disease, which affects the hand function in many older people, may be linked to gene variants inherited from Neanderthals.
-
New report: Fewer PhDs in life sciences
A new report from Vinnova suggests that competency returns in the life science sector are declining.
-
Raised millions to develop a treatment for ´butterfly children´
Fragile as a butterfly’s wing – that’s how people living with Epidermolysis Bullosa are usually described. The Lund-based company Xinnate recently raised SEK 10...
-
Dicots nyemission övertecknad – "Vi har stor tillförsikt"
Investeringsklimatet sägs vara ogästvänligt på sina håll i branschen, men det gäller inte Uppsalabolaget Dicot Pharma och dess potensläkemedel under utveckling....
-
Vd-byte i stamcellsbolag
Biotechbolaget Biolamina har utsett Klaus Langhoff-Roos till ny vd.
-
Novo Nordisk buys drug candidate in billion dollar deal
The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...
-
Are you curious about volume imaging for very large samples?
Exciting ZEISS Webinar!
-
KI’s new President: “We need to work closer together”
A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karol...
-
The first Lyme disease vaccine faces a delay
Pfizer and Valneva’s Lyme disease vaccine, which could be the first of its kind, is facing delays of about a year. The reason is problems at trial sites in the ...
-
Bioarctic går vidare med parkinsonkandidat efter lyckad fas I-studie
Bioarctic meddelar positiva studieresultat i tidig klinisk fas för sin läkemedelskandidat mot Parkinsons sjukdom.
-
A new malaria vaccine offers hope but much more research is still needed
There has long been no vaccine against malaria, but there have been breakthroughs in recent years. However, it is still unclear how we become immune to the mala...
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
Trender inom life science 2025 – Del 4 neuro
Nya alzheimerläkemedel börjar användas, ett nytt MS-läkemedel gör entré och verktyg för att ta aktiva substanser genom blod-hjärnbarriären utvecklas. Dessutom v...
-
Ny CBO hos Bioinvent
Cancerforskningsföretaget Bioinvent har rekryterat Sylvie Ryckebusch till rollen som Chief Business Officer.
-
How critical are the “Spermageddon” reports? – Researchers call for action
A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
Eliceras cancerterapi utvärderas i Kina – "Bred potential"
Göteborgsbaserade Elicera Therapeutics inleder ett samarbete med ett kinesiskt universitet om utveckling av bolagets onkologiska virusterapi ELC-201.
-
Ozempic may benefit hip replacement surgery
The high-profile drug for type 2 diabetes and weight loss may be beneficial in other areas. One such area is for patients undergoing hip replacement surgery, a ...
-
Study: Chat GPT is more empathetic than doctors
The AI tool Chat GPT is not only more accurate when it comes to answering patient questions – the chatbot is also perceived as almost 10 times more empathetic t...
-
Trends and overview: ELRIG "Robotics and Automation"
Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic
-
Suing the company – for NOT developing a new HIV drug
Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...
-
Astra Zeneca licensierar ut Crispr-teknologi
Det amerikanska Crispr-bolaget Synthego kommer att få tillgång till ett genredigeringsenzym från Astra Zeneca genom ett nytecknat licensavtal.
-
Behöver du vätskekylning under noll grader?
SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.